BriaCell Therapeutics (BCT) Competitors C$0.83 -0.02 (-2.35%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarnings BCT vs. SCYB, COM, TH, NVH, COV, ONC, IGX, SVA, PDP, and EMHShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Theratechnologies (TH), Novoheart (NVH), Covalon Technologies (COV), Oncolytics Biotech (ONC), IntelGenx Technologies (IGX), Sernova (SVA), Pediapharm (PDP), and Emerald Health Therapeutics (EMH). These companies are all part of the "biotechnology" industry. BriaCell Therapeutics vs. Scythian Biosciences 138267 (COM.TO) Theratechnologies Novoheart Covalon Technologies Oncolytics Biotech IntelGenx Technologies Sernova Pediapharm Emerald Health Therapeutics Scythian Biosciences (CVE:SCYB) and BriaCell Therapeutics (TSE:BCT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, community ranking, earnings and institutional ownership. Is SCYB or BCT more profitable? Scythian Biosciences' return on equity of 0.00% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Scythian BiosciencesN/A N/A N/A BriaCell Therapeutics N/A -206.01%-122.71% Does the media refer more to SCYB or BCT? In the previous week, Scythian Biosciences' average media sentiment score of 0.00 equaled BriaCell Therapeutics'average media sentiment score. Company Overall Sentiment Scythian Biosciences Neutral BriaCell Therapeutics Neutral Which has stronger earnings & valuation, SCYB or BCT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScythian BiosciencesN/AN/AN/AN/AN/ABriaCell TherapeuticsN/AN/A-C$6M-C$0.50-1.66 Do insiders and institutionals hold more shares of SCYB or BCT? 15.0% of BriaCell Therapeutics shares are held by institutional investors. 9.3% of BriaCell Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor SCYB or BCT? Scythian Biosciences received 35 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 100.00% of users gave BriaCell Therapeutics an outperform vote while only 69.23% of users gave Scythian Biosciences an outperform vote. CompanyUnderperformOutperformScythian BiosciencesOutperform Votes3669.23% Underperform Votes1630.77% BriaCell TherapeuticsOutperform Votes1100.00% Underperform VotesNo Votes SummaryScythian Biosciences and BriaCell Therapeutics tied by winning 3 of the 6 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCT vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$29.75MC$165.68MC$5.14BC$6.07BDividend Yield13.70%3.64%5.09%5.42%P/E Ratio-1.66115.5190.0526.16Price / SalesN/A18,531.021,116.251,332.85Price / CashN/A12.8743.1082.30Price / Book-2.248.594.783.07Net Income-C$6M-C$20.67MC$120.31MC$295.24M7 Day Performance-12.63%-1.05%-1.92%-2.48%1 Month Performance-17.82%174.77%13.65%-0.91%1 Year Performance-86.00%134.18%28.34%33.65% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTBriaCell TherapeuticsN/AC$0.83-2.4%N/A-84.6%C$29.75MN/A-1.6616Gap UpSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AC$2.95-2.6%N/AN/AC$102.19MN/A0.00N/ATHTheratechnologiesN/AC$2.21+2.8%N/A+17.9%C$101.62MC$82.57M-12.28103News CoverageHigh Trading VolumeNVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/ACOVCovalon TechnologiesN/AC$3.49+2.9%N/A+184.0%C$95.63MC$29.20M-87.25N/AONCOncolytics Biotech1.0076 of 5 starsC$1.18flatC$3.50+196.6%-29.6%C$90.70MN/A-3.1129News CoverageHigh Trading VolumeIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpSVASernova1.4623 of 5 starsC$0.22-4.3%C$1.83+733.3%-66.2%C$71.57MN/A-1.691,959Gap DownPDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/AEMHEmerald Health TherapeuticsN/AC$0.26-3.8%N/A+0.0%C$52.28MC$13.02M-0.37161 Related Companies and Tools Related Companies SCYB Alternatives COM Alternatives TH Alternatives NVH Alternatives COV Alternatives ONC Alternatives IGX Alternatives SVA Alternatives PDP Alternatives EMH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:BCT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
